Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays
CA 2366237 A1 · Owner: Pourny, Jean-Louis · Inventors: Treich, Isabelle; Iris, Francois J. M.; Pourny, Jean-Louis
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to methods and compositions for use in screening nucleic acid populations for nucleic acid polymorphisms. The methods, referred to generally as ValiGene?SM~ Mutation Screening Peptide-, Linked (VGMS-PL) methods, are specifically designed for high-throughput genotype mapping and gene expression analysis of animal and plant nucleic acids without requiring a PCR amplification step. In particular the methods , of the invention utilize oligonucleotide probes labeled with distinguishable and identifiable peptide tags, that are captured on addressable antibody arrays.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 16, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 16, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 16, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.